ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...
The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
Preterm babies who receive a hepatitis B virus (HBV) vaccine at birth aren't at increased risk of developing a chronic lung ...
Here’s why doctors recommend getting specific shots at specific times — as well as what happens when parents stray from that ...
Hepatitis B (sometimes referred to as hep B) is a liver infection caused by the hepatitis B virus (HBV). It typically causes symptoms like stomach pain, dark urine, fatigue, fever, jaundice (yellowing ...
About Brelovitug (also known as BJT-778) Brelovitug is a high potency, fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) that targets the surface antigen (anti-HBsAg) of the hepatitis B ...
Sjögren’s antibody testing is done using a blood sample. It checks antibody levels, including anti-SS-A (also called anti-Ro) and anti-SS-B (also called anti-La). Anti-SS-A and anti-SS-B are ...
This represents people living with positive hepatitis C virus antibody status, including those with chronic hepatitis C, those who spontaneously resolved the infection, and those with ...
In connection with the opioid epidemic, hepatitis C rates have risen dramatically. People who share needles, especially opioids, are at risk of contracting hepatitis C. Getting screened and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results